Search Within

Neil Howard Segal

Formats
  1. Meeting Abstract (111)
  2. Journal Article (97)
  3. Review (2)
  4. Book Section (1)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (213)
  2. Gastrointestinal Oncology Service (213)
  3. Solid Tumor Oncology Division (213)
  4. Center for Pancreatic Cancer Research (98)
  5. Surgery (81)
  6. Survivorship Research (80)

More Groups

People
  1. Leonard Saltz (82)
  2. Andrea Cercek Hanjis (70)
  3. Zsofia Stadler (67)
  4. Martin Weiser (61)
  5. Rona Yaeger (61)
  6. Jinru Shia (56)

More People

Years
  1. 2025 (9)
  2. 2024 (15)
  3. 2023 (12)
  4. 2022 (14)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (78)
  2. Annals of Oncology (22)
  3. Clinical Cancer Research (9)
  4. Cancer Research (6)
  5. Journal for ImmunoTherapy of Cancer (6)
  6. Modern Pathology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Oxford University Press (27)
  3. American Association for Cancer Research (21)
  4. Elsevier Inc. (19)
  5. Nature Publishing Group (10)
  6. Biomed Central Ltd (6)

More Publishers

Results (213)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Skin cancers and sarcomas
    Book Section

    Page, D. B.; Segal, N. H.; Momtaz, P.; Halpern, A. C.; Harding, J. J.; Chapman, P. B.; Tap, W. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer
    Journal Article

    Litvak, A.; Cercek, A.; Segal, N.; Reidy-Lagunes, D.; Stadler, Z. K.; Yaeger, R. D.; Kemeny, N. E.; Weiser, M. R.; Pessin, M. S.; Saltz, L.
    Journal of the National Comprehensive Cancer Network (2014)

    Fulltext@MSK | Save
  • False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer
    Meeting Abstract

    Litvak, A. M.; Cercek, A.; Segal, N. H.; Reidy, D. L.; Stadler, Z. K.; Yaeger, R. D.; Kemeny, N. E.; Weiser, M. R.; Pessin, M.; Saltz, L.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer
    Journal Article

    Cercek, A.; Goodman, K. A.; Hajj, C.; Weisberger, E.; Segal, N. H.; Reidy-Lagunes, D. L. ; Stadler, Z. K.; Wu, A. J.; Weiser, M. R.; Paty, P. B.; more...
    Journal of the National Comprehensive Cancer Network (2014)

    Fulltext@MSK | Save
  • Characterization of rectal cancer in patients with Lynch syndrome
    Meeting Abstract

    Stadler, Z. K.; Shia, J.; Goodman, K. A.; Cercek, A.; Segal, N. H.; Reidy, D. L.; Yaeger, R. D.; Nash, G. M.; Temple, L. K. F.; Kemeny, N. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Safety and clinical activity of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in combination with ipilimumab in patients (pts) with advanced melanoma (MEL)
    Meeting Abstract

    Wolchok, J. D.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Reed, K.; Burke, M. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I dose-escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) administered in combination with nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (Pts) with advanced refractory solid tumors
    Meeting Abstract

    Sanbom, R. E.; Sharfman, W. H.; Segal, N. H.; Hodi, F. S.; Wolchok, J. D.; Urba, W. J.; Fox, B. A.; Topalian, S. L.; Pardoll, D. M.; Covello, K. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of the safety, tolerability, pharmacokinetics, and immunoregulatory activity of urelumab (BMS-663513) in subjects with advanced and/or metastatic solid tumors and relapsed/refractory B-cell non-Hodgkin's lymphoma (B-NHL)
    Meeting Abstract

    Melero, I.; Gangadhar, T. C.; Kohrt, H. E.; Segal, N. H.; Logan, T.; Urba, W. J.; Hodi, F. S.; Ott, P. A.; Perez-Gracia, J. L.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chemotherapy first, followed by chemoradiation (CRT) and then surgery, in the management of locally advanced rectal cancer (LARC)
    Meeting Abstract

    Cercek, A.; Goodman, K. A.; Hajj, C.; Weisberger, E.; Segal, N. H.; Reidy, D. L.; Stadler, Z. K.; Wu, A. J. C.; Weiser, M. R.; Paty, P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Induction chemotherapy followed by chemoradiotherapy and total mesenteric excision for locally advanced rectal cancer with resectable metastases
    Meeting Abstract

    Hajj, C.; Cercek, A.; Saltz, L.; Segal, N. H.; Reidy, D. L.; Stadler, Z. K.; Kemeny, N. E.; Wu, A. J. C.; Weiser, M. R.; Paty, P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save